Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow

Jeff S. Isenberg, Fuminori Hyodo, Lisa A. Ridnour, Caitlin S. Shannon, David A. Wink, Murali C. Krishna, David D. Roberts

    Research output: Contribution to journalArticle

    23 Citations (Scopus)

    Abstract

    Nitric oxide (NO) plays important physiological roles in the vasculature to regulate angiogenesis, blood flow, and hemostasis. In solid tumors, NO is generally acknowledged to mediate angiogenic responses to several growth factors. This contrasts with conflicting evidence that NO can acutely increase tumor perfusion through local vasodilation or diminish perfusion by preferential relaxation of peripheral vascular beds outside the tumor. Because thrombospondin 1 (TSP1) is an important physiological antagonist of NO in vascular cells, we examined whether, in addition to inhibiting tumor angiogenesis, TSP1 can acutely regulate tumor blood flow. We assessed this activity of TSP1 in the context of perfusion responses to NO as a vasodilator and epinephrine as a vasoconstrictor. Nitric oxide treatment of wild type and TSP1 null mice decreased perfusion of a syngeneic melanoma, whereas epinephrine transiently increased tumor perfusion. Acute vasoactive responses were also independent of the level of tumor-expressed TSP1 in a melanoma xenograft, but recovery of basal perfusion was modulated by TSP1 expression. In contrast, overexpression of truncated TSP1 lacking part of its CD47 binding domain lacked this modulating activity. These data indicate that TSP1 primarily regulates long-term vascular responses in tumors, in part, because the tumor vasculature has a limited capacity to acutely respond to vasoactive agents.

    Original languageEnglish
    Pages (from-to)886-896
    Number of pages11
    JournalNeoplasia
    Volume10
    Issue number8
    DOIs
    Publication statusPublished - Jan 1 2008

    Fingerprint

    Thrombospondin 1
    Nitric Oxide
    Perfusion
    Neoplasms
    Blood Vessels
    Epinephrine
    Melanoma
    Vasoconstrictor Agents
    Hemostasis
    Vasodilator Agents
    Heterografts
    Vasodilation
    Intercellular Signaling Peptides and Proteins

    All Science Journal Classification (ASJC) codes

    • Cancer Research

    Cite this

    Isenberg, J. S., Hyodo, F., Ridnour, L. A., Shannon, C. S., Wink, D. A., Krishna, M. C., & Roberts, D. D. (2008). Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow. Neoplasia, 10(8), 886-896. https://doi.org/10.1593/neo.08264

    Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow. / Isenberg, Jeff S.; Hyodo, Fuminori; Ridnour, Lisa A.; Shannon, Caitlin S.; Wink, David A.; Krishna, Murali C.; Roberts, David D.

    In: Neoplasia, Vol. 10, No. 8, 01.01.2008, p. 886-896.

    Research output: Contribution to journalArticle

    Isenberg, JS, Hyodo, F, Ridnour, LA, Shannon, CS, Wink, DA, Krishna, MC & Roberts, DD 2008, 'Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow', Neoplasia, vol. 10, no. 8, pp. 886-896. https://doi.org/10.1593/neo.08264
    Isenberg JS, Hyodo F, Ridnour LA, Shannon CS, Wink DA, Krishna MC et al. Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow. Neoplasia. 2008 Jan 1;10(8):886-896. https://doi.org/10.1593/neo.08264
    Isenberg, Jeff S. ; Hyodo, Fuminori ; Ridnour, Lisa A. ; Shannon, Caitlin S. ; Wink, David A. ; Krishna, Murali C. ; Roberts, David D. / Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow. In: Neoplasia. 2008 ; Vol. 10, No. 8. pp. 886-896.
    @article{c249022b9fc04493a22ce06ce8a9c5db,
    title = "Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow",
    abstract = "Nitric oxide (NO) plays important physiological roles in the vasculature to regulate angiogenesis, blood flow, and hemostasis. In solid tumors, NO is generally acknowledged to mediate angiogenic responses to several growth factors. This contrasts with conflicting evidence that NO can acutely increase tumor perfusion through local vasodilation or diminish perfusion by preferential relaxation of peripheral vascular beds outside the tumor. Because thrombospondin 1 (TSP1) is an important physiological antagonist of NO in vascular cells, we examined whether, in addition to inhibiting tumor angiogenesis, TSP1 can acutely regulate tumor blood flow. We assessed this activity of TSP1 in the context of perfusion responses to NO as a vasodilator and epinephrine as a vasoconstrictor. Nitric oxide treatment of wild type and TSP1 null mice decreased perfusion of a syngeneic melanoma, whereas epinephrine transiently increased tumor perfusion. Acute vasoactive responses were also independent of the level of tumor-expressed TSP1 in a melanoma xenograft, but recovery of basal perfusion was modulated by TSP1 expression. In contrast, overexpression of truncated TSP1 lacking part of its CD47 binding domain lacked this modulating activity. These data indicate that TSP1 primarily regulates long-term vascular responses in tumors, in part, because the tumor vasculature has a limited capacity to acutely respond to vasoactive agents.",
    author = "Isenberg, {Jeff S.} and Fuminori Hyodo and Ridnour, {Lisa A.} and Shannon, {Caitlin S.} and Wink, {David A.} and Krishna, {Murali C.} and Roberts, {David D.}",
    year = "2008",
    month = "1",
    day = "1",
    doi = "10.1593/neo.08264",
    language = "English",
    volume = "10",
    pages = "886--896",
    journal = "Neoplasia",
    issn = "1522-8002",
    publisher = "Elsevier Inc.",
    number = "8",

    }

    TY - JOUR

    T1 - Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow

    AU - Isenberg, Jeff S.

    AU - Hyodo, Fuminori

    AU - Ridnour, Lisa A.

    AU - Shannon, Caitlin S.

    AU - Wink, David A.

    AU - Krishna, Murali C.

    AU - Roberts, David D.

    PY - 2008/1/1

    Y1 - 2008/1/1

    N2 - Nitric oxide (NO) plays important physiological roles in the vasculature to regulate angiogenesis, blood flow, and hemostasis. In solid tumors, NO is generally acknowledged to mediate angiogenic responses to several growth factors. This contrasts with conflicting evidence that NO can acutely increase tumor perfusion through local vasodilation or diminish perfusion by preferential relaxation of peripheral vascular beds outside the tumor. Because thrombospondin 1 (TSP1) is an important physiological antagonist of NO in vascular cells, we examined whether, in addition to inhibiting tumor angiogenesis, TSP1 can acutely regulate tumor blood flow. We assessed this activity of TSP1 in the context of perfusion responses to NO as a vasodilator and epinephrine as a vasoconstrictor. Nitric oxide treatment of wild type and TSP1 null mice decreased perfusion of a syngeneic melanoma, whereas epinephrine transiently increased tumor perfusion. Acute vasoactive responses were also independent of the level of tumor-expressed TSP1 in a melanoma xenograft, but recovery of basal perfusion was modulated by TSP1 expression. In contrast, overexpression of truncated TSP1 lacking part of its CD47 binding domain lacked this modulating activity. These data indicate that TSP1 primarily regulates long-term vascular responses in tumors, in part, because the tumor vasculature has a limited capacity to acutely respond to vasoactive agents.

    AB - Nitric oxide (NO) plays important physiological roles in the vasculature to regulate angiogenesis, blood flow, and hemostasis. In solid tumors, NO is generally acknowledged to mediate angiogenic responses to several growth factors. This contrasts with conflicting evidence that NO can acutely increase tumor perfusion through local vasodilation or diminish perfusion by preferential relaxation of peripheral vascular beds outside the tumor. Because thrombospondin 1 (TSP1) is an important physiological antagonist of NO in vascular cells, we examined whether, in addition to inhibiting tumor angiogenesis, TSP1 can acutely regulate tumor blood flow. We assessed this activity of TSP1 in the context of perfusion responses to NO as a vasodilator and epinephrine as a vasoconstrictor. Nitric oxide treatment of wild type and TSP1 null mice decreased perfusion of a syngeneic melanoma, whereas epinephrine transiently increased tumor perfusion. Acute vasoactive responses were also independent of the level of tumor-expressed TSP1 in a melanoma xenograft, but recovery of basal perfusion was modulated by TSP1 expression. In contrast, overexpression of truncated TSP1 lacking part of its CD47 binding domain lacked this modulating activity. These data indicate that TSP1 primarily regulates long-term vascular responses in tumors, in part, because the tumor vasculature has a limited capacity to acutely respond to vasoactive agents.

    UR - http://www.scopus.com/inward/record.url?scp=48249107523&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=48249107523&partnerID=8YFLogxK

    U2 - 10.1593/neo.08264

    DO - 10.1593/neo.08264

    M3 - Article

    C2 - 18670646

    AN - SCOPUS:48249107523

    VL - 10

    SP - 886

    EP - 896

    JO - Neoplasia

    JF - Neoplasia

    SN - 1522-8002

    IS - 8

    ER -